SMS Pharma Gets EIR for Hyderabad API Facility
ECONOMY & POLICY

SMS Pharma Gets EIR for Hyderabad API Facility

SMS Pharmaceuticals Limited announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) facility at Bachupally, Hyderabad. The inspection was conducted between 17th and 21st March 2025.

The inspection concluded with one procedural observation on Form 483, which has already been addressed by the company. The issuance of the EIR marks the formal closure of the audit.

The Hyderabad unit has a manufacturing capacity of 120 kilolitres and specialises in niche, small-volume, high-value molecules. It holds multiple global regulatory approvals including those from USFDA, European Union Good Manufacturing Practice (EU GMP), Korea Food and Drug Administration (KFDA), Brazilian Health Regulatory Agency (ANVISA), Pharmaceuticals and Medical Devices Agency (PMDA), and Central Drugs Standard Control Organisation (CDSCO).

Established in 1990, SMS Pharma serves global clients across over seventy countries, with facilities in Hyderabad and Vizag. The company is supported by in-house research and development capabilities and operates in a wide range of therapeutic categories.

Source:
SMS Pharmaceuticals Limited 

SMS Pharmaceuticals Limited announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) facility at Bachupally, Hyderabad. The inspection was conducted between 17th and 21st March 2025. The inspection concluded with one procedural observation on Form 483, which has already been addressed by the company. The issuance of the EIR marks the formal closure of the audit. The Hyderabad unit has a manufacturing capacity of 120 kilolitres and specialises in niche, small-volume, high-value molecules. It holds multiple global regulatory approvals including those from USFDA, European Union Good Manufacturing Practice (EU GMP), Korea Food and Drug Administration (KFDA), Brazilian Health Regulatory Agency (ANVISA), Pharmaceuticals and Medical Devices Agency (PMDA), and Central Drugs Standard Control Organisation (CDSCO). Established in 1990, SMS Pharma serves global clients across over seventy countries, with facilities in Hyderabad and Vizag. The company is supported by in-house research and development capabilities and operates in a wide range of therapeutic categories. Source: SMS Pharmaceuticals Limited 

Next Story
Infrastructure Energy

US Experts Join ONGC to Contain Assam Gas Leak

A team of international well control experts from the United States has been mobilised to assist Oil and Natural Gas Corporation Limited (ONGC) in containing a gas leak from one of its wells in eastern Assam’s Sivasagar district. The specialists are expected to arrive at the Rudrasagar oilfield site by the evening of 20 June to bolster containment efforts with advanced technical support.The incident occurred on 12 June at well number RDS 147A of rig SKP 135, located at Barichuk in Bhatiapar. The site, operated by private contractor SK Petro Services on behalf of ONGC, experienced a blowout, ..

Next Story
Infrastructure Urban

Attero to Invest Rs 1 Bn to Boost Rare Earth Recycling

E-waste recycling company Attero has announced plans to invest Rs 1 billion to increase its rare earth element (REE) recycling capacity from 300 tonnes to 30,000 tonnes annually over the next 12 to 24 months. The move comes amid tightening global supply and India’s push for critical mineral self-reliance following China’s recent export restrictions on rare earths.“Attero is ready to scale its rare earth recycling capability from one to 100 tonnes per day, reaching 30,000 tonnes annually,” said Nitin Gupta, CEO and Co-Founder. The investment will support extraction of key rare earth ele..

Next Story
Infrastructure Urban

West Bengal to Set Up 3 New IT Parks in North Bengal

The West Bengal Government has announced plans to establish three new IT parks in north Bengal, as part of its broader strategy to enhance the State’s information technology infrastructure. The move comes in response to the growing demand for space in existing facilities, all of which are currently operating at near-full capacity.At present, West Bengal has 22 IT parks, with occupancy levels ranging between 80 per cent and 100 per cent. In Siliguri alone, all three operational IT parks are running at full capacity, prompting the State to expand its presence in the region.“We are now focusi..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?